which is better glp 1 or tirzepatide I compare two weight loss medications with my patients every single week. Here's what the data actually shows. Semaglutide (Ozempic/Wegovy) delivered a 13.7% average weight loss in clinical trials. That's significant. But Not all GLP-1s are the

Semaglutide, a leading GLP-1 receptor agonist, demonstrated a mean weight loss of 14.9% at weekly doses of 2.4 mg, compared with only 2.4% for placebo

Many women find that getting estrogen back on board steadies appetite and sleep

Off-label territory: Using GLP-1 at doses below the therapeutic target for an unlicensed indication (athletic body composition) means your physician is operating outside established guidelines

The possible increase in incidence of breast cancer in association with these 2 agents must be clarified in long-term studies and post-marketing investigations

Retrieved from Quesada, O., Claggett, B., Rodriguez, F., et al